tiprankstipranks
Trending News
More News >
Climb Bio, Inc. (CLYM)
:CLYM
US Market

Climb Bio (CLYM) Similar Stocks

Compare
59 Followers

Comparison Results

Name
Price
Analyst Price Target
Analyst Consensus
Market Cap
P/E Ratio
Yearly Gain
Top Analysts' Price Target
Smart Score
Follow
Climb Bio
$1.17
1 Buy
0 Hold
0 Sell
Moderate Buy
$78.95M
-53.16%
Sangamo Biosciences
$0.71
5 Buy
2 Hold
0 Sell
Moderate Buy
$147.52M
26.07%
Bluebird Bio
$4.77
1 Buy
3 Hold
0 Sell
Hold
$48.46M
-79.44%
Editas Medicine
$1.00
3 Buy
5 Hold
1 Sell
Hold
$85.47M
-85.12%
Intellia Therapeutics
$6.54
15 Buy
4 Hold
1 Sell
Moderate Buy
$686.32M
-74.15%
Crispr Therapeutics AG
$32.38
12 Buy
6 Hold
1 Sell
Moderate Buy
$2.81B
-49.48%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CLYM
Climb Bio
1.26
-1.43
-53.16%
SGMO
Sangamo Biosciences
0.71
0.15
26.79%
BLUE
Bluebird Bio
4.77
-18.43
-79.44%
EDIT
Editas Medicine
1.00
-5.72
-85.12%
NTLA
Intellia Therapeutics
6.54
-18.76
-74.15%
CRSP
Crispr Therapeutics AG
32.38
-31.71
-49.48%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis